Prof. Ullrich Wüllner is a German neurologist and
neuroscientist. A fellow of the German National Academic Foundation
(Studienstiftung), he obtained a doctorate at the Max-Planck-Institute for
Experimental Medicine in Göttingen was a research associate in neurology at
the Massachusetts General Hospital with AB Young and O Isacson (Harvard Medical
School) and worked on the neurochemical anatomy of the basal ganglia,
modulation of glutamate receptors, and excitatory neurotransmission in
Parkinson's disease (PD), using positron emission tomography (PET), high-field
MRI and in-vitro techniques (PMID: 1515582, 15959851, 16631078). He completed
specialist training in Tübingen (board-certified in neurology and
“Habilitation” in 1998 “apoptotic cell death in neurodegenerative diseases”),
set up a research laboratory at the Dept. of Neurology in Bonn, and continued
the investigation of molecular and pharmacological aspects of the pathogenesis
of ataxias (SCA) and PD (PMID: 17941852, 27120258, 28449715). He is currently
head of the Division of Movement Disorders, apl. Prof. of the Medical Faculty
of the Rheinische Friedrich-Wilhelms University Bonn and group leader at the
German Center for Neurodegenerative Diseases (DZNE, Biomarker Parkinson). In a
recent translational clinical project, he leads a team of neurologists,
neurosurgeons, and radiologists using MRI-guided focused ultrasound (MRgFUS)
for minimally invasive treatment of tremors (PMID: 30406441).
